Navigation Links
Inexpensive Compound Could Treat Severe Diarrhea
Date:6/17/2008

Finding may be 'magic bullet' to help miilions of children in developing world, study says

TUESDAY, June 17 (HealthDay News) -- A new compound that may lead to an inexpensive, easy-to-take treatment for diarrhea has been discovered by researchers at the University of Texas Health Science Center at Houston.

This finding may prove especially important for developing countries, where diarrhea is a major cause of child deaths. Diarrhea kills an estimated 1.6 million to 2.5 million children a year, according to information published by the World Health Organization.

The new compound -- a pyridopyrimidine derivative -- targets E. coli and other enterotoxigenic strains of bacteria that cause acute secretory diarrhea. These bacteria produce toxins that stimulate the linings of the intestines, causing them to secrete excessive fluid, resulting in diarrhea.

In preclinical tests on animals infected with diarrhea-causing bacteria, the new compound was associated with a significant reduction in intestinal fluid secretion. The compound also reduced fluid build-up in laboratory tests on human cells. There was no indication of toxicity caused by the compound.

The research was published in the June 16 online edition of the journal Proceedings of the National Academy of Sciences.

"While this research looks extremely promising as a preventive or therapeutic intervention in Third World diarrheal disease and traveler's diarrhea, much work remains to be done to move into clinical trials and eventual therapeutic approval," study senior author Dr. Ferid Murad cautioned in a prepared statement.

A drug based on this compound may also prove effective in treating inflammatory bowel disease and some endocrine disorders, Murad said.

The discovery of this compound is "a promising lead," said Dr. Stanley G. Schultz, a cellular signaling expert at the University of Texas Medical School at Houston who was not involved in the study.

"An inexpensive drug that could block the intestinal secretory pathway, with minimal side effects, would be a 'magic bullet' that would not only save millions of lives in many parts of the developing world, but would also save the billions of dollars that are lost annually because of diarrhea throughout the world. It would truly be a treatment of diarrhea rather than a treatment of the consequences of diarrhea," Schultz said in a prepared statement.

Currently, there is no effective way to directly treat secretory diarrhea. Treatment is aimed at minimizing fluid loss through intravenous or oral rehydration.

More information

The American College of Gastroenterology has more about diarrheal diseases.



-- Robert Preidt



SOURCE: University of Texas Health Science Center at Houston, news release, June 16, 2008


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Study Finds Nearly One-Third of All Inexpensive Earrings Examined Tested Positive for Nickel
2. Study: Before a CT scan or angiogram, many people should take inexpensive drug to protect kidneys
3. Inexpensive Online Pain Education Program for Physicians as Effective as Live Presentations by National Experts
4. UCR chemists use green chemistry to produce amines, chemical compounds used widely in industry
5. Telik Announces Patents on Compounds Related to TELINTRA
6. New PA Economic Study: Bush Medicare Cuts Compound State Medicaid Crisis
7. Red Wine Compound Helps Heart, May Slow Aging
8. New Compound Slows HIV Replication
9. Preliminary Results from Phase 2 Genzyme Study Highlight Potential of Novel Oral Compound for Gaucher Disease
10. Patients, Doctors, Pharmacists Praise Bipartisan House Resolution on Compounded Hormones Containing Estriol
11. Grapefruit Compound Inhibits Hepatitis C Virus
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2017)... SALT LAKE CITY, UTAH (PRWEB) , ... April ... ... Josée Côté as Account Manager for the North East region. Côté has 20+ ... operations and consulting. Prior to Phytomer, Côté worked with an array of high-end ...
(Date:4/28/2017)... ... April 28, 2017 , ... Rob Lowe is a popular actor that has ... presence to an educational purpose as the host of the “Informed” series. The program ... a recent episode, the series focuses on thyroid cancer. , Although thyroid cancer is ...
(Date:4/27/2017)... , ... April 27, 2017 , ... ... Insights in Incentives, Rewards, and Recognition: A Nudge Guide," a groundbreaking analysis of ... field. Offering practical takeaways to apply immediately to IRR programs, the report highlights ...
(Date:4/27/2017)... Neb. (PRWEB) , ... April 27, 2017 , ... ... was named the 2017 North American CAREGiverSM of the Year for her extraordinary ... selects one of its 60,000 North American professional caregivers for the prestigious award ...
(Date:4/27/2017)... GA (PRWEB) , ... April 27, 2017 , ... Are ... a tragic spike in water-related accidents and drownings during the summer. While most of ... is that these situations occur every day. Very few people are taking the time ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... , April 20, 2017 Research and ... Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, ... report to their offering. ... The global pharmacogenomics market was valued at US$ 7,167.6 Mn ... by 2024, expanding at a CAGR of 5.6% from 2016 ...
(Date:4/20/2017)... LUND, Sweden , April 20, 2017 /PRNewswire/ ... OTCQX: NEVPF) ("NeuroVive") today announced positive preclinical ... company,s preclinical compound for non-alcoholic steatohepatitis (NASH), ... NV556 has previously ... STAM™ NASH model. Today, NeuroVive,s scientists present ...
(Date:4/19/2017)... April 19, 2017 /PRNewswire/ - CRH Medical Corporation (TSX: CRH) (NYSE MKT: CRHM) ... & Co. Healthcare Investor Conference 2017 at the Sheraton Hotel in ... , Chief Executive Officer of the Company is scheduled to present ... Richard Bear and the Chairman of the Board, Tony ... ...
Breaking Medicine Technology: